Ledger.Open graph →
SEC Form D · filed May 2, 2022

Castle Creek Biosciences, Inc

Offering
$112.8M
Sold
$112.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Exton, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Mary B. Spellman · Exton, PAExecMatthew J. Gantz · Exton, PAExec · DirectorW. B. Middlekauff · Exton, PAExecPatrick J. Morris · Chicago, ILDirectorAntonio J. Gracias · Chicago, ILDirectorMark J. Graf · Exton, PADirectorJeffrey S. Aronin · Chicago, ILDirectorPedro Checa · Kirkland, WAExecErika L. Taylor · DENVER, CODirectorNate Armstrong · Sarasota, FLDirectorJennie Choboter · VANCOUVER, British Columbia, CanadaExecMichael Parton · Grand Cayman, Cayman IslandsExec · DirectorLeon Rhule · Grand Cayman, Cayman IslandsDirectorSD Ariston Manager, LLC · Akron, OHDirectorSharon R. Malka · Yavne, L3Exec · DirectorStephen T. Wills · Yavne, L3ExecMike Knauss · New York, NYDirectorAndrew Atherton · Tempe, AZExecSue Payton · Broomfield, CODirectorJeff Babione · Broomfield, CODirectorEvan Dreyfuss · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗